Study identification

PURI

https://redirect.ema.europa.eu/resource/50801

EU PAS number

EUPAS50800

Study ID

50801

Official title and acronym

DARWIN EU® Prevalence of rare blood cancers in Europe

DARWIN EU® study

Yes

Study countries

Belgium
Germany
Netherlands
Spain
United Kingdom

Study description

In this study the prevalence of rare blood cancers (follicular lymphoma, diffuse large B-Cell lymphoma, multiple myeloma, chronic lymphocytic leukaemia, acute myeloid leukaemia, acute lymphocytic leukaemia) will be assessed.

Study status

Finalised
Research institution and networks

Institutions

University of Oxford

Networks

Contact details

Edward Burn

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
EMA
Study protocol
Initial protocol
English (1.04 MB - PDF)View document
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable